Biora Therapeutics, Inc. Convertible Notes Payable, Current
Biora Therapeutics, Inc. had Convertible Notes Payable, Current of $4.53 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleNotesPayableCurrent · last filed 2024-11-14
- 2024-09-30: Convertible Notes Payable, Current $4.53M.
- 2023-12-31: Convertible Notes Payable, Current $0.00.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2024-09-30 | $4.53M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-14 |